or Try an Advanced Search...

    Technical Analysis for MIST - Milestone Pharmaceuticals Inc.

    Grade Last Price % Change Price Change
    F 1.34 1.52% 0.02
    MIST closed up 1.52 percent on Monday, July 1, 2024, on 41 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical MIST trend table...
    Date Alert Name Type % Chg
    1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Gapped Up Strength 0.00%
    Lower Bollinger Band Touch Weakness 1.52%
    Boomer Sell Setup Bearish Swing Setup 3.88%
    Inside Day Range Contraction 3.88%
    Below Lower BB Weakness 3.88%
    Gapped Down Weakness 3.88%
    Lower Bollinger Band Touch Weakness 3.88%
    Older End-of-Day Signals for MIST ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 9 hours ago
    Rose Above Previous Day's High about 9 hours ago
    Rose Above 10 DMA about 9 hours ago
    Up 5% about 9 hours ago
    Up 3% about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    MIST Chart by TradingView
    Basic chart:

    Profile

    Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes drugs for the treatment of cardiovascular indications. It offers Etripamil that completed Phase 2 clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for treating Atrial Fibrillation and Angina. The company was founded in 2003 and is headquartered in Montréal, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cardiology Cardiac Arrhythmia Atrial Fibrillation Angina Circulatory System Cardiovascular System Tachycardia Ventricular Tachycardia

    Is MIST a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 12 Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024
    Jun 7 It Looks Like Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO May Expect Their Salary To Be Put Under The Microscope
    May 31 Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
    May 29 Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™
    May 22 Milestone Pharmaceuticals Partners with Arrhythmia Alliance on SVT Awareness
    May 13 Milestone Pharmaceuticals GAAP EPS of -$0.21 beats by $0.05
    May 13 Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
    May 2 Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024
    Apr 3 Milestone® Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference
    Apr 1 Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and European Heart Rhythm Association Annual Conferences
    See more MIST news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.86
    52 Week Low 1.22
    Average Volume 161,711
    200-Day Moving Average 2.05
    50-Day Moving Average 1.56
    20-Day Moving Average 1.41
    10-Day Moving Average 1.35
    Average True Range 0.08
    RSI (14) 35.06
    ADX 45.01
    +DI 8.88
    -DI 21.53
    Chandelier Exit (Long, 3 ATRs) 1.39
    Chandelier Exit (Short, 3 ATRs) 1.45
    Upper Bollinger Bands 1.54
    Lower Bollinger Band 1.27
    Percent B (%b) 0.25
    BandWidth 18.78
    MACD Line -0.08
    MACD Signal Line -0.07
    MACD Histogram -0.0012
    Fundamentals Value
    Market Cap 44.87 Million
    Num Shares 33.5 Million
    EPS -1.38
    Price-to-Earnings (P/E) Ratio -0.97
    Price-to-Sales 12.28
    Price-to-Book 1.87
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.45
    Resistance 3 (R3) 1.45 1.42 1.43
    Resistance 2 (R2) 1.42 1.39 1.42 1.42
    Resistance 1 (R1) 1.38 1.38 1.37 1.38 1.42
    Pivot Point 1.35 1.35 1.34 1.35 1.35
    Support 1 (S1) 1.31 1.32 1.30 1.31 1.26
    Support 2 (S2) 1.28 1.31 1.28 1.26
    Support 3 (S3) 1.24 1.28 1.25
    Support 4 (S4) 1.24